Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.19 EUR
−331.86 M EUR
713.62 M EUR
145.55 M
About Ionis Pharmaceuticals, Inc.
Sector
CEO
Brett P. Monia
Headquarters
Carlsbad
Website
Founded
1989
FIGI
BBG000FHW982
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
IONS5397611
Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026Yield to maturity
2.64%
Maturity date
Apr 1, 2026
IONS5835891
Ionis Pharmaceuticals, Inc. 1.75% 15-JUN-2028Yield to maturity
2.25%
Maturity date
Jun 15, 2028
Explore more bonds
Frequently Asked Questions
The current price of ISI is 34.65 EUR — it has increased by 0.26% in the past 24 hours. Watch IONIS PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange IONIS PHARMACEUTICALS INC stocks are traded under the ticker ISI.
ISI stock has risen by 0.20% compared to the previous week, the month change is a 7.78% rise, over the last year IONIS PHARMACEUTICALS INC has showed a −25.48% decrease.
We've gathered analysts' opinions on IONIS PHARMACEUTICALS INC future price: according to them, ISI price has a max estimate of 74.82 EUR and a min estimate of 35.49 EUR. Watch ISI chart and read a more detailed IONIS PHARMACEUTICALS INC stock forecast: see what analysts think of IONIS PHARMACEUTICALS INC and suggest that you do with its stocks.
ISI stock is 2.52% volatile and has beta coefficient of 0.44. Track IONIS PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is IONIS PHARMACEUTICALS INC there?
Today IONIS PHARMACEUTICALS INC has the market capitalization of 5.48 B, it has decreased by −0.79% over the last week.
Yes, you can track IONIS PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
IONIS PHARMACEUTICALS INC is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
ISI earnings for the last quarter are −0.85 EUR per share, whereas the estimation was −1.01 EUR resulting in a 15.61% surprise. The estimated earnings for the next quarter are −1.07 EUR per share. See more details about IONIS PHARMACEUTICALS INC earnings.
IONIS PHARMACEUTICALS INC revenue for the last quarter amounts to 120.35 M EUR, despite the estimated figure of 116.37 M EUR. In the next quarter, revenue is expected to reach 130.33 M EUR.
ISI net income for the last quarter is −126.17 M EUR, while the quarter before that showed −61.87 M EUR of net income which accounts for −103.95% change. Track more IONIS PHARMACEUTICALS INC financial stats to get the full picture.
No, ISI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2024, the company has 927.00 employees. See our rating of the largest employees — is IONIS PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IONIS PHARMACEUTICALS INC EBITDA is −312.49 M EUR, and current EBITDA margin is −42.05%. See more stats in IONIS PHARMACEUTICALS INC financial statements.
Like other stocks, ISI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IONIS PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IONIS PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IONIS PHARMACEUTICALS INC stock shows the sell signal. See more of IONIS PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.